Stock Price
0.13
Daily Change
-0.01 -7.41%
Monthly
13.64%
Yearly
32.98%
Q3 Forecast
0.13

Starpharma Holdings reported AUD2.43M in Sales Revenues for its fiscal semester ending in December of 2024.


Sales Change Date
Medical Developments International AUD 7.54M 0 Dec/2023
Mesoblast USD 1.56M 950K Dec/2024
Neuren Pharmaceuticals AUD 194.1M 163.93M Dec/2024